Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0W7WC
|
|||
Former ID |
DNAP001684
|
|||
Drug Name |
Ivacaftor
|
|||
Synonyms |
Kalydeco (TN)
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Cystic fibrosis [ICD-11: CA25; ICD-10: E84, E84.9; ICD-9: 277] | Approved | [1], [2], [3] | |
Company |
Vertex
|
|||
Structure |
![]() |
Download2D MOL |
||
Formula |
C24H28N2O3
|
|||
Canonical SMILES |
CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C
|
|||
InChI |
1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)
|
|||
InChIKey |
PURKAOJPTOLRMP-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 873054-44-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
24902571, 28764112, 40723266, 104253162, 118855344, 123051083, 124757031, 124950685, 125163835, 125299328, 125434146, 126661313, 126731535, 131480767, 134964550, 135264255, 135626653, 135653729, 135692075, 135727452, 136367331, 136367911, 136926964, 137031731, 137626819, 137626820, 144116089, 152134181, 152258419, 160645564, 160647255, 160874442, 162011579, 162037465, 162202744, 163894050, 164042021, 172919866, 175266660, 175427103, 178101159, 184819711, 187072829, 198993065, 223381530, 223471420, 223683825, 223705162, 224174132, 226685555
|
|||
ChEBI ID |
CHEBI:66901
|
|||
ADReCS Drug ID | BADD_D01220 | |||
SuperDrug ATC ID |
R07AX02
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | cAMP-dependent chloride channel (CFTR) | Target Info | Modulator | [4] |
KEGG Pathway | ABC transporters | |||
cAMP signaling pathway | ||||
AMPK signaling pathway | ||||
Gastric acid secretion | ||||
Pancreatic secretion | ||||
Bile secretion | ||||
Vibrio cholerae infection | ||||
Reactome | ABC-family proteins mediated transport | |||
WikiPathways | ABC-family proteins mediated transport |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4342). | |||
REF 2 | Nat Rev Drug Discov. 2013 Feb;12(2):87-90. | |||
REF 3 | Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357. | |||
REF 4 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.